Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report.

Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Abstract Text:

This preliminary study evaluated prognostic indicators or predictors of response to cognitive therapy. The sample included 37 unipolar outpatients with moderate to severe major nonpsychotic depressive disorder, according to Research Diagnostic Criteria. Demographic characteristics (sex, age, marital status, and education), pretreatment severity measures (Hamilton Rating Scale for Depression [HRSD] and Beck Depression Inventory [BDI]), pretreatment cognitive measures (Dysfunctional Attitudes Scale [DAS] and Attributional Style Questionnaire Failure Composite [ASQ-F]), and historical features (length of illness, length of current episode, number of episodes, and age of onset) were used in multiple regression models to predict response. In accord with previous findings, patients who had higher (rather than lower) pretreatment HRSD, BDI, or DAS scores and were single (rather than married) showed a poorer response to cognitive therapy, according to the HRSD. Furthermore, married outpatients with high DAS scores or single patients with low DAS scores showed an intermediate response to cognitive therapy, while single patients with high DAS scores responded the least. Generally, effects were stronger when response was assessed according to clinician-rated severity measures rather than patient self-reports.

Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Publishing Authors By Initials

For similar behavioral disciplines and activities: psychological tests: psychometrics research abstracts see: behavioral disciplines and activities: psychological tests: psychometrics research

PUBMED ID PMID:

MEDLINE DATE:

Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Psychiatry research

VOLUME: 37

Page Numbers: 245-60

Journal Abbreviation: Psychiatry Res

ISSN: 0165-1781

DAY: 17

MONTH: Jun

YEAR: 1991

Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7911385

Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Keywords Mesh Terms:

KEYWORDS: Psychometrics

MESH TERMS: statistics & numerical data

Chemical & Substance for Abstract: Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report.

AFFILIATION: Mental Health Clinical Research Center, Dept. of Psychiatry, U.T. Southwestern Medical Center, Dallas 75235.

Country: IRELAND

AGENCY: United States NIMH

GRANT: MH-45043

ACRONYM: MH

MEDLINETA: Psychiatry Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report Related Publications

• A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
• A pharmacological analysis of stimulant-induced increases in smoking.
• Acceptability of second-step treatments to depressed outpatients: a STAR*D report.
• Accumulated Risk Factors for Lifestyle Disease in Indian Pre-Adolescent Vegetarian and Non-Vegetarian Girls: 2594: Board #141 June 2 8:00 AM - 9:30 AM.
• Bone marrow-derived cells and arterial disease.
• Bupropion in the treatment of outpatients with asthma and major depressive disorder.
• Canine pericardial effusion: diagnosis,treatment, and prognosis.
• Canine pericardial effusion: pathophysiology and cause.
• Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
• Customizing treatment to the patient: adaptive treatment strategies.
• Effectiveness trials in mood disorders.
• Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
• Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status.
• Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression.
• Insured and non-insured depressed outpatients: how do they compare?
• Limitations in efficacy of antidepressant monotherapy.
• Lymphocyte tracking and interactions in secondary lymphoid organs.
• Pregnancy-associated congestive heart failure in a cat.
• Reconstructive options for failed flatfoot surgery.
• Reversible myocardial depression associated with sepsis in a dog.
• Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.
• Sertraline as a first-line treatment for cholestatic pruritus.
• Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
• Substance abuse and quality of life among severely mentally ill consumers: a longitudinal modelling analysis.
• Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.
• The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine.
• The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.
• Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia.
• Voltage-gated sodium channel blockers for the treatment of neuropathic pain.
• Vs02 aortic calcification: studies in patients with peripheral artery disease and a mouse model.